Reducing greenhouse gas emissions from medical products — a podcast episode on sustainability in the pharmaceutical industry

Health | 8/24/2022

PODCAST: Efforts for a greener future in the pharmaceutical industry

Environmental issues are receiving a lot of attention worldwide, and people are becoming more and more aware of the environmental impacts of their actions. This also applies to the pharma industry. In this podcast episode, created by Orion Pharma and hosted by Hanna Hisinger-Mölkänen, sustainability issues are discussed in the context of medicine and pharma by Professor Paula Rytilä (Orion’s Chief Medical Officer), and sustainability expert Ville Vartiainen, MSc/MD/PhD. What does it mean when a product is carbon neutral? What important actions can be taken to minimize the climate impacts of medical products, and what has Orion already achieved? Tune in to this episode and learn the answers to these questions and more!

The key things that any company can do to minimize their environmental impact are to first identify out where greenhouse gas emissions originate in their processes, and then take action to decrease them. It is also possible to aim even higher and move towards carbon neutrality, as Orion has done. In this podcast episode, you will hear more about the concept of carbon neutrality, and find out what key things everyone can do to advance sustainability in medicine — such as using medications as prescribed and disposing of medical waste according to local instructions.

LISTEN NOW

LISTEN ON SPOTIFY

LISTEN ON APPLE PODCASTS

You might be interested in these:

Facts
Care for a cleaner world – Why aiming for carbon neutral care matters, and what it means for asthma and COPD

Care for a cleaner world – Why aiming for carbon neutral care matters, and what it means for asthma and COPD

The detrimental impact of health care on environment and climate can be mitigated through minimising greenhouse gas (GHG) emissions and offsetting – creating carbon neutral care options also for asthma and COPD.

Facts
Dry Powder Inhalers have the power to reduce the carbon footprint of inhalers

Dry Powder Inhalers have the power to reduce the carbon footprint of inhalers

How to minimize CO2 emissions without compromising good care?


Orion invests in research and development of treatment options for people with asthma and COPD while also developing the design and usability of the Easyhaler® inhaler device platform. The focus is on safety and quality in each step of the product life cycle while taking care of the environment. All aspects of sustainability - social, economic and environmental - are carefully considered in the whole product life cycle. Sustainability is entwined in the whole process from R&D through manufacturing, including patient use and the disposal of old inhalers.

You can download the Orion Sustainability Report 2021 here